Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aveanna Healthcare Holdings (AVAH) EBITDA Margin (2020 - 2026)

Aveanna Healthcare Holdings (AVAH) has disclosed EBITDA Margin for 6 consecutive years, with 8.62% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBITDA Margin rose 193.0% year-over-year to 8.62%, compared with a TTM value of 10.09% through Sep 2025, up 388.0%, and an annual FY2024 reading of 7.38%, up 633.0% over the prior year.
  • EBITDA Margin was 8.62% for Q3 2025 at Aveanna Healthcare Holdings, down from 13.58% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 13.58% in Q2 2025 and bottomed at 103.03% in Q3 2022.
  • Average EBITDA Margin over 5 years is 2.69%, with a median of 6.4% recorded in 2023.
  • The sharpest move saw EBITDA Margin skyrocketed 68220bps in 2021, then plummeted -10998bps in 2022.
  • Year by year, EBITDA Margin stood at 4.46% in 2021, then plummeted by -741bps to 28.6% in 2022, then surged by 121bps to 6.12% in 2023, then surged by 44bps to 8.8% in 2024, then decreased by -2bps to 8.62% in 2025.
  • Business Quant data shows EBITDA Margin for AVAH at 8.62% in Q3 2025, 13.58% in Q2 2025, and 9.26% in Q1 2025.